The purpose of this study is to investigate the time course of PF-00241939 concentration in the blood following dosing by oral inhalation from dry powder inhalers.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Enrollment
36
PF-00241939 300ug using Inhaler A
PF-00241939 300ug using Inhaler B
PF-00241939 300ug using Inhaler C
Pfizer Investigational Site
Singapore, Singapore
Plasma pharmacokinetic parameters: AUClast & Cmax.
Time frame: 48 hours
Plasma pharmacokinetic parameters: AUC0-12, AUC0-24, AUCinf, Tmax and t½.
Time frame: 48 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.